The DAX Index Closes 1.31% Higher

The DAX Index decreased 245 points or 0.94 percent on Friday to close at 25795 points. The decline was led by Siemens Energy (-7.13%), Infineon (-6.70%) and Deutsche Bank (-3.29%). On the upside, the strongest performers were Bayer (4.71%), Scout24 (2.54%) and Beiersdorf (2.23%).

Frankfurt's DAX fell further to close about 0.9% down at 25,819 on Friday, snapping a four-day winning streak, pressured by rising oil prices and the seloff in tech stocks. Growing concerns about a possible renewed US military strike against Iran weighed, while AI concerns intensified following disappointing results from US big technology companies. Attention was also on a batch of economic data from major European economies. Preliminary figures showed German inflation eased more than anticipated in October, while the economy continued to expand at a modest pace. Among single stocks, Infineon Technologies and AI-related Siemens Energy and Hochtief posted the biggest losses, ranging between 3%-7.1%. Other top decliners included Deutsche Bank (-3.6%) and Siemens (-2.9%). On the upside, Bayer shares surged over 5% after securing a unanimous jury verdict in its favour in a lawsuit alleging that its Roundup weedkiller The index booked gains of around 2.5% over both the week and the month.

Frankfurt's DAX traded 0.2% down on Friday, halting a four-day winning streak, pressured by rising oil prices and tech weakness. Investor enthusiasm for artificial intelligence faced another test, as disappointing earnings from Amazon and Intel triggered a broader sell-off that swept through European technology stocks. Meanwhile, market participants braced for a deluge of economic data, particularly inflation and GDP, while also eyeing more corporate earnings. Siemens Energy, Infineon Technologies, Hochtief were among the worst performers, with losses ranging between 2%-5%. On the upside, Bayer shares surged 4% after securing a unanimous jury verdict in its favour in a lawsuit alleging that its Roundup weedkiller caused cancer in three women, offering a potential boost to its efforts to contain mounting litigation risks. The benchmark index was on track to post gains of more than 3% over both the week and the month.